Investigational GLP-1 Receptor Agonist effective in Lowering HbA1c in Early Type 2 Diabetes: NEJM Jacinthlyn Sylvia5 July 2025 9:00 AM ISTA recent phase III randomized trial found an investigational oral small-molecule GLP-1 receptor agonist significantly reducing the glycated hemoglobin...
Once-Weekly Insulin Efsitora Matches Daily Insulin in Type 2 Diabetes Management: NEJM Dr Riya Dave3 July 2025 9:00 AM ISTIn the QWINT-1 phase III trial, once-weekly insulin efsitora demonstrated non-inferior efficacy and safety compared to once-daily insulin glargine...
Add on Cagrilintide to Semaglutide tied to Significant Weight Loss in diabetics and non diabetics in Obesity Trials Dr. Shravani Dali26 Jun 2025 9:00 AM ISTResearchers have found in phase IIIa REDEFINE 1 trial that Addition of investigational cagrilintide to GLP-1 agonist semaglutide led to 20.4% body...
Zimislecel Therapy Achieves Insulin Independence in Majority of Type 1 Diabetes Patients in Phase 2 trial Jacinthlyn Sylvia24 Jun 2025 9:00 AM ISTIn phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after receiving zimislecel (formerly...
Bevacizumab and erlotinib combo effective in papillary renal-cell carcinoma patients: NEJM Jacinthlyn Sylvia23 Jun 2025 10:00 PM ISTA new study published in The New England Journal of Medicine showed that bevacizumab and erlotinib together demonstrated efficacy in individuals with...
No Mortality Difference Found Between Oral and IV Rehydration in Malnourished Children: NEJM Dr Riya Dave23 Jun 2025 8:45 PM ISTResearchers discovered that intravenous (IV) rehydration therapy did not decrease mortality rates as compared to oral rehydration therapy in children...
Elinzanetant Significantly Reduces Vasomotor Symptoms in Women on Endocrine Therapy: NEJM Dr Riya Dave10 Jun 2025 9:15 AM ISTA recent study published in The New England Journal of Medicine has found that elinzanetant, a therapy targeted at neurokinin receptors, significantly...
Once Weekly Mazdutide effectvely reduced body weight in obese individuals: NEJM Jacinthlyn Sylvia9 Jun 2025 12:15 PM ISTA new study published in The New England Journal of Medicine showed that once weekly mazdutide at a dosage of 4 mg or 6 mg for 32 weeks resulted in...
Navigational bronchoscopy effective in diagnosing peripheral pulmonary nodules: NEJM Jacinthlyn Sylvia5 Jun 2025 8:00 PM ISTA new study published in The New England Journal of Medicine found that for patients with peripheral pulmonary nodules ranging in size from 10 to 30...
Albuterol-budesonide combo lowered risk of a severe asthma exacerbation: NEJM Jacinthlyn Sylvia1 Jun 2025 8:30 PM ISTA new study published in The New England Journal of Medicine showed that the participants with asthma who remained uncontrolled despite therapy were...
Efruxifermin Fails to Significantly Reduce Fibrosis in Compensated Cirrhosis: Study Dr Riya Dave22 May 2025 8:00 AM ISTAccording to a new study published in The New England Journal of Medicine, efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue,...
Oveporexton Boosts Wakefulness and Cuts Cataplexy in Narcolepsy Type 1, Phase 2 Trial Finds Medha Baranwal17 May 2025 8:15 AM ISTFrance: A new phase 2 clinical trial published in The New England Journal of Medicine has shown that oveporexton (TAK-861), an oral orexin receptor...
